The Effect of Local Injectet GH on the Collagen Synthesis in the Ligamentum Patella
NCT01158612 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12
Last updated 2011-11-07
Summary
Tendon and ligament injuries are a frequent problem among athletes but also in the general population. The healing process is a prolonged process, and complete recovery of tissue strength is nearly never reached. The purpose of this study is to examine the effect of local injection of human Growth Hormone on tendon collagen synthesis.
Conditions
- Growth Hormone
- Elderly
Interventions
- DRUG
-
Growth Hormone
infusion of Growth hormone in the patella tendon.
Sponsors & Collaborators
-
Bispebjerg Hospital
collaborator OTHER -
University of Aarhus
lead OTHER
Principal Investigators
-
Mette Hansen, PH.D.
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 55 Years
- Max Age
- 70 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2010-08-31
- Primary Completion
- 2011-07-31
- Completion
- 2011-08-31
Countries
- Denmark
More Related Trials
-
Insulin Sensitivity and Substrate Metabolism Before and After Treatment in Patients With Growth Hormone Deficiency
NCT00646815 ·Status: COMPLETED ·Phase: NA
-
Prevention of Growth Retardation by Early Treatment With Growth Hormone (GH) in Children With CJA Treated by Corticosteroid Therapy
NCT00174291 ·Status: TERMINATED ·Phase: PHASE3
-
Comparative Validation of the Growth Hormone Releasing Hormone and Arginine Test for the Diagnosis of Adult Growth Hormone Deficiency
NCT01060488 ·Status: COMPLETED ·Phase: PHASE3
-
Long Term Effect of Somatropin in Subjects With Intrauterine Growth Retardation
NCT01734447 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Recombinant Human Growth Hormone on Height Velocity in Subjects With Idiopathic Short Stature
NCT01778023 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of rhIGF-1 on Bone Metabolism in Adolescent Girls With Anorexia Nervosa
NCT00720122 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Growth Hormone Treatment in Juvenile Idiopathic Arthritis
NCT00420251 ·Status: COMPLETED ·Phase: PHASE3
-
Growth and Asymmetric diMethylArginine
NCT03422081 ·Status: COMPLETED
-
Usability and Tolerability of the Norditropin NordiFlex® Injection Device in Children Never Previously Treated With Growth Hormone
NCT01327924 ·Status: COMPLETED
-
Influence of Adherence to Growth Hormone Therapy (GHT) With Norditropin® on Near Final Height in Patients With Growth Hormone Deficiency (GHD) and Born Small for Gestational Age (SGA)
NCT03972345 ·Status: ENROLLING_BY_INVITATION
-
Controlled Study to Evaluate the Efficacy and Safety of the Treatment With Growth Hormone in Tibia Fractures
NCT00254514 ·Status: COMPLETED ·Phase: PHASE2
-
D3-GHR Polymorphism and Turner Syndrome
NCT00443144 ·Status: COMPLETED
-
Generation of Biological Samples Positive to Somatropin for Anti-doping Control
NCT04042428 ·Status: COMPLETED ·Phase: PHASE1
-
Growth Hormone's Effect on the Cardiovascular System
NCT00397319 ·Status: TERMINATED
-
Non-interventional Study of Patients Using Norditropin® for Growth Hormone Deficiency or Turner Syndrome
NCT01604161 ·Status: COMPLETED
-
Validation of Macimorelin as a Test for Adult Growth Hormone Deficiency
NCT02558829 ·Status: COMPLETED ·Phase: PHASE3
-
Growth Response in Girls With Turner Syndrome
NCT01734486 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Growth Hormone (GH) Deficiency and Growth Hormone Replacement on Serum Fibroblast Growth Factor 21 (FGF21)
NCT02243852 ·Status: WITHDRAWN
-
Sustained Release Formulation of Somatropin (rDNA Origin)for Injection
NCT00600808 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study to Evaluate the Efficacy of Somatropin in Adults With Growth Hormone Deficiency Caused by Trauma and/or Head Injury
NCT00638053 ·Status: TERMINATED ·Phase: PHASE4
-
Growth Hormone Treatment of Young Growth Hormone-Deficient Adults
NCT00187993 ·Status: UNKNOWN
-
Dose Study in Growth Hormone Deficient Adults Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC126-0083
NCT00715689 ·Status: COMPLETED ·Phase: PHASE2
-
Special Survey for Long Term Application
NCT01516229 ·Status: COMPLETED
-
Study of an Extended-Release, Crystalline Formulation of Recombinant Human Growth Hormone (ALTU-238) in Growth Hormone Deficient Adults to Determine Pharmacokinetics, Pharmacodynamics, and Drug Safety
NCT00297713 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Lixisenatide on the Effect of Pituitary Hormones
NCT05804513 ·Status: UNKNOWN ·Phase: PHASE4